Site icon Market Globalist

Why Did ENZC Stock Plummet In Last Trading?

AMD Stock

AMD Stock

Enzolytics Inc. (OTCPINK: ENZC) has been trading in a $0.1133 to $0.1435 range, closing its last trading day down -4.73 percent at $0.1248. Enzolytics stock fell over -56.69% this month; on average 43.75M shares were traded during the month. A significant development also could not prevent the ENZC stock from falling.

What was the announcement?

Enzolytics is a drug company committed to the commercialization of its protein-based drug products for treating infectious diseases. Studies have shown that ENZC’s flagship compound ITV-1, an Inactivated Pepsin Fraction suspension, is effective in the treatment of HIV/AIDS patients. Porcine pepsin is the active drug compound of ITV-1, and it has been demonstrated that ITV-1 modulates the immune system.

Read More

In an important development, recent research indicates that the monoclonal antibodies for the Enzolytics are uniquely focused on the targets on the Coronavirus that are conservatively present on the UK, Brazil, and South African variant strains.

Exit mobile version